Selectis Health (GBCS) Invested Capital (2011 - 2025)

Selectis Health (GBCS) has 15 years of Invested Capital data on file, last reported at $7.2 million in Q4 2025.

• Quarterly Invested Capital fell 47.55% year-over-year to $7.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.2 million (down 47.55% YoY) and the FY2025 annual result came in at $7.2 million, down 47.55% from the prior year.
• Invested Capital retreated to $7.2 million in Q4 2025 per GBCS's latest filing, from $12.9 million in the prior quarter.
• The five-year high for Invested Capital was $22.2 million in Q4 2023, with the low at $1.4 million in Q3 2023.
• Average Invested Capital over 5 years is $9.0 million, with a median of $7.7 million recorded in 2024.
• Year-over-year, Invested Capital sank 90.57% in 2021 and surged 583.54% in 2023.
• Selectis Health's Invested Capital stood at $9.4 million in 2021, then sank by 65.48% to $3.2 million in 2022, then surged by 583.54% to $22.2 million in 2023, then plunged by 38.22% to $13.7 million in 2024, then sank by 47.55% to $7.2 million in 2025.
• Business Quant data shows GBCS's Invested Capital at $7.2 million in Q4 2025, $12.9 million in Q3 2025, and $12.3 million in Q2 2025.